Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Tenofovir-induced Leukocytoclastic Vasculitis.

Al-Busafi SA, Al-Suleimani A, Al-Hamadani A, Rasool W.

Oman Med J. 2017 Sep;32(5):429-431. doi: 10.5001/omj.2017.80.

2.

Vasculitic Neuropathy Following Exposure to a Glyphosate-based Herbicide.

Kawagashira Y, Koike H, Kawabata K, Takahashi M, Ohyama K, Hashimoto R, Iijima M, Katsuno M, Sobue G.

Intern Med. 2017;56(11):1431-1434. doi: 10.2169/internalmedicine.56.8064. Epub 2017 Jun 1.

3.

Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment.

Shim S, Jung CY.

Tuberc Respir Dis (Seoul). 2017 Apr;80(2):210-211. doi: 10.4046/trd.2017.80.2.210. Epub 2017 Mar 31. No abstract available.

4.

Successful Corticosteroid Treatment for Purpura Fulminans Associated with Quinolone.

Okamura I, Nakamura Y, Katsurada Y, Sato K, Ikeda T, Kimura F.

Intern Med. 2016;55(20):3047-3051. Epub 2016 Oct 15.

5.

Nimesulide induced leukocytoclastic vasculitis and hepatitis: a case report.

Bhattacharya PK, Barman B, Roy A, Jamil M, Lyngdoh M, Mishra J.

Springerplus. 2015 Jun 30;4:302. doi: 10.1186/s40064-015-1081-9. eCollection 2015.

6.

The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features.

Loricera J, Calvo-Río V, Ortiz-Sanjuán F, González-López MA, Fernández-Llaca H, Rueda-Gotor J, Gonzalez-Vela MC, Alvarez L, Mata C, González-Lamuño D, Martínez-Taboada VM, González-Gay MA, Blanco R.

Medicine (Baltimore). 2013 Nov;92(6):331-43. doi: 10.1097/MD.0000000000000009.

7.

Preliminary classification criteria for the cryoglobulinaemic vasculitis.

De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, Ferri C, Ferraccioli GF, Quartuccio L, Corazza L, De Marchi G, Ramos Casals M, Voulgarelis M, Lenzi M, Saccardo F, Fraticelli P, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Mazzaro C, Pioltelli P, Steinfeld S, Lamprecht P, Bombardieri S, Galli M.

Ann Rheum Dis. 2011 Jul;70(7):1183-90. doi: 10.1136/ard.2011.150755. Epub 2011 May 13.

8.

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).

Luqmani RA, Suppiah R, Grayson PC, Merkel PA, Watts R.

Clin Exp Immunol. 2011 May;164 Suppl 1:11-3. doi: 10.1111/j.1365-2249.2011.04358.x. Review.

9.

Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report.

Brown K, Martin J, Zito S.

J Med Case Rep. 2010 Jul 1;4:204. doi: 10.1186/1752-1947-4-204.

10.

Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor.

Mwirigi NW, Thomas CF.

Case Rep Med. 2009;2009:941258. doi: 10.1155/2009/941258. Epub 2010 Feb 24.

11.

Hepatitis C- and human immunodeficiency virus-induced hypersensitivity vasculitis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Koolaee RM, Singer O, Bass A, Winchester R, Seshan S, Erkan D.

HSS J. 2010 Feb;6(1):102-7. doi: 10.1007/s11420-009-9141-8. Epub 2009 Nov 17. No abstract available.

12.

Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia.

Patarroyo PA, Restrepo JF, Rojas SA, Rondón F, Matteson EL, Iglesias-Gamarra A.

J Autoimmune Dis. 2009 Feb 27;6:1. doi: 10.1186/1740-2557-6-1.

13.

Hypersensitivity vasculitis induced by cefoperazone/sulbactam.

Islek I, Baris S, Katranci AO, Ariturk E, Gurses N.

Ann Clin Microbiol Antimicrob. 2003 Jan 3;2:1.

14.

Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.

Ribbens C, Martin y Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, Houssiau FA, Malaise MG.

Ann Rheum Dis. 2002 Feb;61(2):161-6.

15.

Benign cutaneous polyarteritis nodosa in children below 10 years of age--a clinical experience.

Kumar L, Thapa BR, Sarkar B, Walia BN.

Ann Rheum Dis. 1995 Feb;54(2):134-6.

Supplemental Content

Support Center